VR Logo

Nectar Lifesciences Limited


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1995

Chairman: Sanjiv Goyal

Managing Director: Sanjiv Goyal

Group: --

Listing: NSE: NECLIFE, BSE: 532649

Headquarters: SAS Nagar Dist, Punjab

Website: www.neclife.com

Key Facts

Market cap: R 300.51 Cr

Revenue (TTM): R 2,664.68 Cr

Earnings (TTM): R 41.67 Cr

Cash: R 21.83 Cr

Total Debt: R 903.45 Cr

Promoters' ownership: 55.80%

Liquidity: Moderate

52 Week range: R 7.10 - 18.40

Face value: R1.00

Shares outstanding: 22,42,60,970

10 Years Aggregate:

  • CFO: 1,696.18 Cr
  • EBITDA: 2,479.05 Cr
  • Net Profit: 693.25 Cr

Stock Performance

Time Period Nectar Lifesciences S&P BSE Healthcare S&P BSE Small Cap
YTD11.9317.93-15.54
1 month-4.233.294.22
3 months24.2013.75-15.99
1 Year-26.2917.97-22.54
3 Years-27.164.50-8.90
5 Years-15.47-0.111.33
10 Years-9.6311.122.98
As on 03-Jun-2020
Year Nectar Lifesciences S&P BSE Small Cap S&P BSE Healthcare
2019-41.16-6.85-3.55
2018-46.80-23.41-5.89
201718.0359.640.49
2016-39.671.77-12.88
201551.686.7615.06
201489.2269.2447.43
2013-10.14-11.2322.55